Filing metadata

Accession number
0001140361-25-019003
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
May 14, 2025
Reporting period
May 12, 2025
Description
Insider transaction

Explore SEC Filings Hub